An Exploratory Study of the Safety and Efficacy of Prophylactic Immunomodulatory Treatment in Myozyme-naive Cross-Reacting Immunologic Material (CRIM[-]) Patients With Infantile-Onset Pompe Disease
Clinical trial NCT00701129 · COMPLETED
Trial details
- NCT number
- NCT00701129
- Sponsor
- Genzyme, a Sanofi Company
- Status
- COMPLETED
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2009-10-01
- Primary completion
- 2013-03-01
- Enrollment
- 4
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.